(Q40633373)

22 September 2017

1 reference

title

Anti-cytokine nature of natural human immunoglobulin: one possible mechanism of the clinical effect of intravenous immunoglobulin therapy (English)

1 reference

22 September 2017

Abe Y

1

1 reference

22 September 2017

Horiuchi A

series ordinal

2

1 reference

22 September 2017

Miyake M

series ordinal

3

1 reference

22 September 2017

Kimura S

series ordinal

4

1 reference

22 September 2017

publication date

1 June 1994

1 reference

22 September 2017

published in

Immunological Reviews

1 reference

22 September 2017

volume

139

1 reference

22 September 2017

page(s)

5-19

1 reference

Tumor necrosis factor-alpha mediates the early pathology in Salmonella infection of the gastrointestinal tract.

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1994.TB00854.X

Autoantibodies to cytokines--friends or foes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1994.TB00854.X

The B5 monoclonal human autoantibody binds to cell surface TNF alpha on human lymphoid cells and cell lines and appears to recognize a novel epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1994.TB00854.X

The role of cachectin/TNF in endotoxic shock and cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1994.TB00854.X

Evaluation of the role of cytokines in autoimmune disease: the importance of TNF alpha in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1994.TB00854.X

Studies on the role of tumor necrosis factor in murine and human autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1994.TB00854.X

Tumor necrosis factor alpha in autoimmunity: pretty girl or old witch?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1994.TB00854.X

Native interleukin 1 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1994.TB00854.X

Effect of late administration of anti-TNF alpha antibodies on a Salmonella infection in the mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1994.TB00854.X

A tumor necrosis factor binding protein (TNF-BP)-physiological antagonist of TNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1994.TB00854.X

Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1994.TB00854.X

Intravenous immunoglobulin therapy of autoimmune and systemic inflammatory diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1994.TB00854.X

A human inhibitor of tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1994.TB00854.X

Anti?tumor necrosis factor therapy abrogates autoimmune demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1994.TB00854.X

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1994.TB00854.X

The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1994.TB00854.X

Interleukin 1 potentiates the lethal effect of tumor necrosis factor alpha/cachectin in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1994.TB00854.X

10.1111/J.1600-065X.1994.TB00854.X

21 January 2018

Identifiers

DOI

1 reference

22 September 2017

1 reference